# A Relative Bioavailability Study of Acetaminophen Extended Release Gel Tabs 650 mg Under Fasting Condition

> **NCT01523080** · NA · COMPLETED · sponsor: **Ranbaxy Laboratories Limited** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Acetaminophen

## Key facts

- **NCT ID:** NCT01523080
- **Lead sponsor:** Ranbaxy Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2006-05
- **Final completion:** 2006-07
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2012-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01523080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01523080, "A Relative Bioavailability Study of Acetaminophen Extended Release Gel Tabs 650 mg Under Fasting Condition". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01523080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*